FEED TEST


feed should appear below....

Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting
2024-05-28

Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
2024-05-09

Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024
2024-05-08

Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference
2024-05-07

SECOND FEED